Search Results 1-10 of 15617 for %EC%9D%B5%EC%82%B0%EC%B6%9C%EC%9E%A5%EC%83%B5%ED%95%B4%EB%B9%84%EC%B9%98%E3%80%90%E3%85%8Br%ED%86%A1:VB20%E3%80%91

  1. Hypertension - Mayo Clinic Biobank

    Joseph A. Murray, M.D., has identified in previous research that olmesartan (Benicar), a commonly prescribed blood pressure medication, causes severe ...

  2. An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas - Mayo Clinic

    ... B-Cell Lymphoma (PMBL) and Mediastinal Gray Zone Lymphoma (MGZL). Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  3. Blood pressure chart: What your reading means - Mayo Clinic

    Talk to a healthcare professional about taking one or more medicines. 140 or higher, or, 90 or higher, Stage 2 hypertension, Maintain or adopt a healthy ...

  4. Laboratories - Mayo Clinic Research

    C. Cancer Biology and Translational Research: John A. Copland III · Cancer Research and Cellular Therapies: Januario E. Castro · Cardiovascular Disease and ...

  5. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    The primary purpose of Parts A and B of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of BIIB067 in adults with Amyotrophic ...

  6. Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia ...

  7. A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    ... B-cell Lymphoma (R/R DLBCL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

  9. Laboratories - Mayo Clinic Research

    V. Vaccine Research Group: Gregory A. Poland, Richard B. Kennedy, Inna G. Ovsyannikova · Vascular and Interventional Radiology Translational Research: ...

  10. Left Ventricular Remodeling Post-TAVR - Mayo Clinic

    There has been a paradoxical finding in clinical trials with severe AS patients that LV mass regression is greater and faster after surgical AVR compared to ...